Pfizer Just Canned One of Its Ozempic Killers. What's Next?

Pfizer Just Canned One of Its Ozempic Killers. What's Next?

Source: 
Motley Fool
snippet: 
  • Pfizer discontinued one of its candidates to treat diabetes and obesity.
  • Even if it hadn't been discontinued, competing medicines would likely win out.
  • Don't hold your breath for the company's other candidate accomplishing much.